Scout Bio

Philadelphia, United States

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

$33.0M raised

Oct 2021

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Scout Bio raised?

Scout Bio has raised $33.0M in total funding. The most recent round was Series B. The last funding was announced in October 2021.

Who are Scout Bio's investors?

Scout Bio's investors include Adage Capital Management, OrbiMed, Correlation Ventures, Frazier Healthcare Partners, Digitalis Ventures.

Where is Scout Bio headquartered?

Scout Bio is headquartered in Philadelphia, United States.

What does Scout Bio do?

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

What stage is Scout Bio at?

Scout Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 19, 2021.

MLA

"Scout Bio — Funding & Investors." VCBacked, October 19, 2021, https://www.vcbacked.co/company/scout-bio. Accessed July 2, 2026.

APA

VCBacked. (2021). Scout Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/scout-bio

Wikipedia (cite web)

{{cite web |title=Scout Bio — Funding & Investors |url=https://www.vcbacked.co/company/scout-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 19, 2021.